Schumer Includes Cannabinoid Pathway For Supplements In Cannabis Legalization Draft Bill
Joined by Wyden And Booker, Majority Leader Also Proposes Setting Safe Daily Level
Executive Summary
Draft bill proposes rules not only on producing and marketing marijuana, but on using in supplements ingredients derived from cannabis plants classified as hemp. Some supplement industry stakeholders see draft as delivering on industry requests but others say it goes too far.
You may also be interested in...
US Cannabis Legalization Cultivated By House Has Thorny Forecast For Harvest In Senate
Absence of hemp provisions in House bill could be a problem with Senate Democrats, who have drafted legislation not only on producing, marketing and possessing marijuana but also using in supplements ingredients classified as hemp. Still, Senate passage of cannabis legalization is unlikely.
VMS Market Regulation Gets Targeted Funding In US FDA Budget; OTC Switches Get Question
In report explaining congressional intent for omnibus spending bill, House and Senate appropriators note concerns about, and target $5m for, regulation of supplement market. Question on moving drug ingredients from Rx to nonprescription not accompanied by targeted funding.
Naturopath, Regulatory Expert MacKay Returns To DC As CHPA’s Supplement Industry Strategy Chief
Consumer Healthcare Products Association names Duffy MacKay as its first senior VP for dietary supplements. Former CRN executive moves from CV Sciences back into trade group world.